Become a Provider | OPTIFAST

The OPTIFAST® program is proven to get results

proven-benefits-img-wide@2x

Losing at least 5% of one’s starting weight is considered “medically significant” because it is associated with improvements in risk factors or incidence of certain diseases and conditions in at-risk people who suffer from obesity

After 2 years (based on approximately 610 participants in the study)

  • 40%of patients maintained more than half their weight loss
  • 78% of men and 60%of women maintained medically significant weight loss

After 5 years (based on approximately 335 participants)

  • Approximately 50% of patients maintained medically significant weight loss

The OPTIFAST® program offers complete protocols for:

  • Medical monitoring (lab work and EKG are program requirements)
  • Comprehensive patient education with the Lifestyle Education SeriesTM (LES) to support behavior modification
  • Nutritionally complete OPTIFAST® meal replacements that take the guesswork out of eating
  • The use of OPTIFAST® in prepration for and following weight loss surgery

Resources include:

  • Support from weight loss experts
  • Staff training, including OPTIFAST® program management and medical monitoring of patients
  • Customizable marketing materials
  • A nationally recognized brand with clinically proven results

Provider Registration Form

In addition to offering unparalleled resources for patients, the OPTIFAST® program provides unique advantages to you, including skilled weight loss experts, medical and program staff training, business development tools, education curriculum for patients, and exclusive distribution. Patients aren’t the only ones who can achieve long-term success. OPTIFAST® clinics benefit from ongoing assistance, support, and training.

to receive more information about becoming an OPTIFAST® provider.

OPTIFAST® Medical Director

OPTIFAST Medical Director

Jamy Ard, M.D.

Medical Director, OPTIFAST®
Nestlé Healthcare Nutrition

Jamy Ard, M.D. is a Professor in the Department of Epidemiology and Prevention and the Department of Medicine at Wake Forest University Baptist Medical Center. He is also co-director of the Wake Forest Baptist Health Weight Management Center, directing medical weight management programs. Dr. Ard received an M.D. and completed internal medicine residency training at Duke University Medical Center. Following completion of his residency training, he was selected to serve as a chief resident in internal medicine at Duke. He also received formal training in clinical research as a fellow at the Center for Health Services Research in Primary Care at the Durham VA Medical Center. During this time, he participated in a focused research experience on lifestyle interventions for hypertension and obesity at the Duke Hypertension Center.

Dr. Ard’s research interests include clinical management of obesity and strategies to improve cardiometabolic risk using lifestyle modification. In particular his work has focused on developing and testing medical strategies for the treatment of obesity in special populations, including African Americans, those with type 2 diabetes and older adults. Dr. Ard has participated in several major NIH funded multi-center trials including Dietary Approaches to Stop Hypertension (DASH), DASH-sodium, PREMIER, and Weight Loss Maintenance Trial. He has been conducting research on lifestyle modification since 1995 and has received research funding from a variety of federal and foundation sources, including the National Institutes of Health and the Robert Wood Johnson Foundation. His work has been published in numerous scientific journals and he has been a featured presenter at several national and international conferences and workshops dealing with obesity.

Dr. Ard has more than 20 years of experience in clinical nutrition and obesity. Prior to joining the faculty at Wake Forest in 2012, Dr. Ard spent nine years at the University of Alabama at Birmingham in the Department of Nutrition Sciences. Dr. Ard has served on several expert panels and guideline development committees, including the Institute of Medicine Committee on Consequences of Sodium Reduction in Populations, the AHA/ACC/TOS Guideline Panel on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults, and currently, the American Psychological Association Obesity Guideline Development Panel. He is also serving on the editorial board for the American Journal of Clinical Nutrition and the International Journal of Obesity.

References:

  • Wadden TA, Foster GD, Letizia KA, Stunkard AJ. A multicenter evaluation of a proprietary weight reduction program for the treatment of marked obesity. Arch Intern Med. 1992 May;152(5):961-6.  
  • Wadden TA, Frey DL.  A Multicenter Evaluation of a Proprietary Weight Loss Program for the Treatment of Marked Obesity: A Five-Year Follow-Up.  International Journal of Eating Disorders. 1997;022:02:203-212.
  • Drawert S, Bedford K, Largent D. Change in glucose, blood pressure, and cholesterol with weight loss in medically obese patients. Obesity Research. 1996;4(S1)67S.
  • Ard J, Schroeder M, Kivilaid K, Swanson J, Hayes E, Olesen M. Effects of the practical application of a medically monitored, comprehensive weight management program on risk factors associated with the metabolic syndrome. International Journal of Obesity.  (Ard et al., J Obes Wt Loss Ther 2014, S4)